Canadian and Foreign Drug Importation Won't Provide Choice OR Cost Savings for Patients and Plan Sponsors - Here's Why:
At a time when prescription drug prices are so high that several states are considering legislation to make foreign prescription drug importation legal, PUTT again warns legislators and consumers that this proposed “solution” will NOT fix the problem of high drug prices.
As pharmacists, our first concern is for patient safety. But we also know (a little too well) how drug prices force some patients into rationing medicine or not filling a prescription, and that legislators are responding to constituents’ concerns for drug cost. Still, foreign drug importation, while it may provide some superficial cost savings, will not provide the kind of choice or value patients need.
Consider the proposed plan in Florida. PUTT requested public records for Flagler County’s much-touted CanaRx program, and learned a few things:
Lesson #1: Transparency works. Under Florida’s “sunshine laws” we can see the 2018 quarterly cost reports for prescriptions available under CanaRx. On the report, the green highlighted items are prescriptions ALREADY available as generic in the U.S.